373 related articles for article (PubMed ID: 28527810)
1. HIF-1α-stabilizing agent FG-4497 rescues human CD34
Nowlan B; Futrega K; Brunck ME; Walkinshaw G; Flippin LE; Doran MR; Levesque JP
Exp Hematol; 2017 Aug; 52():50-55.e6. PubMed ID: 28527810
[TBL] [Abstract][Full Text] [Related]
2. HIF-1α is required for hematopoietic stem cell mobilization and 4-prolyl hydroxylase inhibitors enhance mobilization by stabilizing HIF-1α.
Forristal CE; Nowlan B; Jacobsen RN; Barbier V; Walkinshaw G; Walkley CR; Winkler IG; Levesque JP
Leukemia; 2015 Jun; 29(6):1366-78. PubMed ID: 25578474
[TBL] [Abstract][Full Text] [Related]
3. HIF prolyl hydroxylase inhibitor FG-4497 enhances mouse hematopoietic stem cell mobilization via VEGFR2/KDR.
Bisht K; Brunck ME; Matsumoto T; McGirr C; Nowlan B; Fleming W; Keech T; Magor G; Perkins AC; Davies J; Walkinshaw G; Flippin L; Winkler IG; Levesque JP
Blood Adv; 2019 Feb; 3(3):406-418. PubMed ID: 30733301
[TBL] [Abstract][Full Text] [Related]
4. Functional analysis of human hematopoietic repopulating cells mobilized with granulocyte colony-stimulating factor alone versus granulocyte colony-stimulating factor in combination with stem cell factor.
Hess DA; Levac KD; Karanu FN; Rosu-Myles M; White MJ; Gallacher L; Murdoch B; Keeney M; Ottowski P; Foley R; Chin-Yee I; Bhatia M
Blood; 2002 Aug; 100(3):869-78. PubMed ID: 12130497
[TBL] [Abstract][Full Text] [Related]
5. Different Human Immune Lineage Compositions Are Generated in Non-Conditioned NBSGW Mice Depending on HSPC Source.
Hess NJ; Lindner PN; Vazquez J; Grindel S; Hudson AW; Stanic AK; Ikeda A; Hematti P; Gumperz JE
Front Immunol; 2020; 11():573406. PubMed ID: 33193358
[TBL] [Abstract][Full Text] [Related]
6. Combined G-CSF and Plerixafor enhance hematopoietic recovery of CD34
Arcangeli ML; Brault P; Bourhis JH; Kuhnowskie F; Henry E; Barroca V; Koscielny S; Pflumio F; Amsellem S
Exp Hematol; 2020 Jun; 86():15-20.e2. PubMed ID: 32450206
[TBL] [Abstract][Full Text] [Related]
7. The HGF/c-Met axis synergizes with G-CSF in the mobilization of hematopoietic stem/progenitor cells.
Jalili A; Shirvaikar N; Marquez-Curtis LA; Turner AR; Janowska-Wieczorek A
Stem Cells Dev; 2010 Aug; 19(8):1143-51. PubMed ID: 20021260
[TBL] [Abstract][Full Text] [Related]
8. The role of granulocyte colony-stimulating factor in mobilization and transplantation of peripheral blood progenitor and stem cells .
Haas R; Murea S
Cytokines Mol Ther; 1995 Dec; 1(4):249-70. PubMed ID: 9384679
[TBL] [Abstract][Full Text] [Related]
9. Mobilization of hematopoietic stem cells with highest self-renewal by G-CSF precedes clonogenic cell mobilization peak.
Winkler IG; Wiercinska E; Barbier V; Nowlan B; Bonig H; Levesque JP
Exp Hematol; 2016 Apr; 44(4):303-14.e1. PubMed ID: 26827874
[TBL] [Abstract][Full Text] [Related]
10. Adrenaline administration promotes the efficiency of granulocyte colony stimulating factor-mediated hematopoietic stem and progenitor cell mobilization in mice.
Chen C; Cao J; Song X; Zeng L; Li Z; Li Y; Xu K
Int J Hematol; 2013 Jan; 97(1):50-7. PubMed ID: 23224606
[TBL] [Abstract][Full Text] [Related]
11. Nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mouse as a model system to study the engraftment and mobilization of human peripheral blood stem cells.
van der Loo JC; Hanenberg H; Cooper RJ; Luo FY; Lazaridis EN; Williams DA
Blood; 1998 Oct; 92(7):2556-70. PubMed ID: 9746798
[TBL] [Abstract][Full Text] [Related]
12. Accelerated lymphocyte reconstitution and long-term recovery after transplantation of lentiviral-transduced rhesus CD34+ cells mobilized by G-CSF and plerixafor.
Uchida N; Bonifacino A; Krouse AE; Metzger ME; Csako G; Lee-Stroka A; Fasano RM; Leitman SF; Mattapallil JJ; Hsieh MM; Tisdale JF; Donahue RE
Exp Hematol; 2011 Jul; 39(7):795-805. PubMed ID: 21549175
[TBL] [Abstract][Full Text] [Related]
13. Endothelial progenitor cells promote efficient ex vivo expansion of cord blood-derived hematopoietic stem/progenitor cells.
Qu Q; Liu L; Chen G; Xu Y; Wu X; Wu D
Cytotherapy; 2016 Mar; 18(3):452-64. PubMed ID: 26857234
[TBL] [Abstract][Full Text] [Related]
14. The alpha4beta1 and alpha5beta1 integrins mediate engraftment of granulocyte-colony-stimulating factor-mobilized human hematopoietic progenitor cells.
Carstanjen D; Gross A; Kosova N; Fichtner I; Salama A
Transfusion; 2005 Jul; 45(7):1192-200. PubMed ID: 15987366
[TBL] [Abstract][Full Text] [Related]
15. Long-Acting IL-33 Mobilizes High-Quality Hematopoietic Stem and Progenitor Cells More Efficiently Than Granulocyte Colony-Stimulating Factor or AMD3100.
Alt C; Yuan S; Wu F; Stankovich B; Calaoagan J; Schopies S; Wu JY; Shen J; Schneider D; Zhu Y; Zhao XY; Lippow SM; Bauzon M
Biol Blood Marrow Transplant; 2019 Aug; 25(8):1475-1485. PubMed ID: 31163266
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte colony-stimulating factor and an RARalpha specific agonist, VTP195183, synergize to enhance the mobilization of hematopoietic progenitor cells.
Herbert KE; Walkley CR; Winkler IG; Hendy J; Olsen GH; Yuan YD; Chandraratna RA; Prince HM; Lévesque JP; Purton LE
Transplantation; 2007 Feb; 83(4):375-84. PubMed ID: 17318068
[TBL] [Abstract][Full Text] [Related]
17. Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial.
Crees ZD; Rettig MP; Jayasinghe RG; Stockerl-Goldstein K; Larson SM; Arpad I; Milone GA; Martino M; Stiff P; Sborov D; Pereira D; Micallef I; Moreno-Jiménez G; Mikala G; Coronel MLP; Holtick U; Hiemenz J; Qazilbash MH; Hardy N; Latif T; García-Cadenas I; Vainstein-Haras A; Sorani E; Gliko-Kabir I; Goldstein I; Ickowicz D; Shemesh-Darvish L; Kadosh S; Gao F; Schroeder MA; Vij R; DiPersio JF
Nat Med; 2023 Apr; 29(4):869-879. PubMed ID: 37069359
[TBL] [Abstract][Full Text] [Related]
18. Peripheral blood stem cell mobilization by granulocyte colony-stimulating factor alone and engraftment kinetics following autologous transplantation in children and adolescents with solid tumor.
Watanabe H; Watanabe T; Suzuya H; Wakata Y; Kaneko M; Onishi T; Okamoto Y; Abe T; Kawano Y; Kagami S; Takaue Y
Bone Marrow Transplant; 2006 Apr; 37(7):661-8. PubMed ID: 16489358
[TBL] [Abstract][Full Text] [Related]
19. Beyond CD34+ cell dose: impact of method of peripheral blood hematopoietic stem cell mobilization (granulocyte-colony-stimulating factor [G-CSF], G-CSF plus plerixafor, or cyclophosphamide G-CSF/granulocyte-macrophage [GM]-CSF) on number of colony-forming unit-GM, engraftment, and Day +100 hematopoietic graft function.
Alexander ET; Towery JA; Miller AN; Kramer C; Hogan KR; Squires JE; Stuart RK; Costa LJ
Transfusion; 2011 Sep; 51(9):1995-2000. PubMed ID: 21392017
[TBL] [Abstract][Full Text] [Related]
20. Expression of integrin α2 receptor in human cord blood CD34+CD38-CD90+ stem cells engrafting long-term in NOD/SCID-IL2Rγ(c) null mice.
Wong WM; Sigvardsson M; Åstrand-Grundström I; Hogge D; Larsson J; Qian H; Ekblom M
Stem Cells; 2013 Feb; 31(2):360-71. PubMed ID: 23165626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
